Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin for cerebral autoregulation and delayed ischemic deficits after aneurysmal subarachnoid haemorrhage
ISRCTN30515245Phase 2Completed
- Sponsor
- Record Provided by the NHSTCT Register - 2006 Update - Department of Health
- Start
- Jan 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2, randomised, double-blind trial in subarachnoid hemorrhage (SAH) and stroke comparing Erythropoietin with Placebo (2 arms). Primary endpoints: Vasospasm on transcranial Doppler and Abnormal cerebral autoregulation. Started Jan 2005; status: completed.
02
Drugs
erythropoietin
03
Conditions
subarachnoid hemorrhage (SAH)stroke
Beyond the preview
Go deeper on ISRCTN30515245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN30515245.